Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00564772 · ClinicalTrials.gov registry record · Phase 4
Raltegravir Kaletra Pharmacokinetics
A Phase 4 study, sponsored by Allina Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00564772 is a Phase 4 study that has completed, run by Allina Health System. The registered enrollment target is 15 participants.
The verdict
NCT00564772, a Phase 4 study, has completed, sponsored by Allina Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This will be an open-label, 3-period, fixed sequence study in young, healthy, male and female subjects of the pharmacokinetic interaction between raltegravir and Kaletra.
Interventions
- DRUG Raltegravir, lopinavir, ritonavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-11 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00564772
The ClinicalTrials.gov registry entry for NCT00564772 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allina Health System, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Raltegravir, lopinavir, ritonavir is the first listed.
NCT00564772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00564772 about?
NCT00564772 is a clinical study titled "Raltegravir Kaletra Pharmacokinetics". This will be an open-label, 3-period, fixed sequence study in young, healthy, male and female subjects of the pharmacokinetic interaction between raltegravir and Kaletra.
What is the current status of trial NCT00564772?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2007-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00564772?
The interventions under investigation include: Raltegravir, lopinavir, ritonavir (DRUG).
Who is sponsoring clinical trial NCT00564772?
This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.